SYSTEM AND METHOD FOR DETECTING, DIAGNOSING, AND TREATING CARDIOVASCULAR DISEASE

WIPO Patent Application WO2005000206

A3

An apparatus for treating cardiovascular disease in a medical patient includes one or more sensors (155), an implantable housing (7), at least one implantable lead (10), a signal processor (157), and a signaling device (166). The sensor (155) is operable to generate a sensor signal indicative of fluid pressure within the left atrium (36) of the heart (33). The implantable housing (7) includes a cardiac rhythm management apparatus (159), such as a pacemaker or a defibrillator. The cardiac rhythm management apparatus (159) includes an electrode (15), which is operable to deliver an electrical stimulus to a location in the heart (33). The electrical stimulus is delivered based at least in part on the sensor signal. The lead (10) is coupled to the implantable housing (7), and to the electrode (14). The signal processor (157) is operable to generate a processor output indicative of a treatment, and is based at least in part on the sensor signal. The signaling device (166) is operable to generate at least two distinct treatment signais distinguishable from one another by the patient. Each signal is indicative of a différent therapeutic treatment, and is based at least in part on the processor output.

EIGLER NEAL L (US)
WHITING JAMES S PH D (US)
MANN BRIAN (US)

PCT/US2004/016186

April 07, 2005

May 12, 2004

Click for automatic bibliography generation  

SAVACOR INC (US)
EIGLER NEAL L (US)
WHITING JAMES S PH D (US)
MANN BRIAN (US)

A61B5/0215; A61N1/365; A61N1/362; (IPC1-7): A61N1/362

US6381493B1	2002-04-30
US6480744B2	2002-11-12
US20020013613A1	2002-01-31
US20030055461A1	2003-03-20
US4984572A	1991-01-15
US6580946B2	2003-06-17

See also references of EP 1622680A4

View/Download PDF      PDF Help

Previous Patent: METHODS AND COMPOSITIONS FOR MODULATING SERUM CORTISOL LEVELS

Next Patent: PCDGF RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF